Skip to main content

Advertisement

Log in

Percutaneous Nonviral Delivery of Hepatocyte Growth Factor in an Osteotomy Gap Promotes Bone Repair in Rabbits: A Preliminary Study

  • Symposium: Advances in Limb Lengthening and Reconstruction
  • Published:
Clinical Orthopaedics and Related Research

Abstract

Hepatocyte growth factor (HGF) was initially identified in cultured hepatocytes and subsequently reported to induce angiogenic, morphogenic, and antiapoptotic activity in various tissues. These properties suggest a potential influence of HGF on bone healing. We asked if gene transfer of human HGF (hHGF) into an osteotomy gap with a hemagglutinating virus of Japan-envelope (HVJ-E) vector promotes bone healing in rabbits. HVJ-E that contained either hHGF or control plasmid was percutaneously injected into the osteotomy gap of rabbit tibias on Day 14. The osteotomy gap was evaluated by radiography, pQCT, mechanical tests, and histology at Week 8. The expression of hHGF was evaluated by reverse transcriptase–polymerase chain reaction and immunohistochemistry at Week 3. Radiography, pQCT, and histology suggested the hHGF group had faster fracture healing. Mechanical tests demonstrated the hHGF group had greater mechanical strength. The injected tissues at 3 weeks expressed hHGF mRNA by reverse transcriptase–polymerase chain reaction. hHGF-positive immunohistochemical staining was observed in various cells at the osteotomy gap at Week 3. The data suggest delivery of hHGF plasmid into the osteotomy gap promotes fracture repair, and HGF could become a novel agent for fracture treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1A–B
Fig. 2
Fig. 3A–C
Fig. 4A–B
Fig. 5A–B
Fig. 6
Fig. 7
Fig. 8A–B

Similar content being viewed by others

References

  1. Alden TD, Pittman DD, Hankins GR, Beres EJ, Engh JA, Das S, Hudson SB, Kerns KM, Kallmes DF, Helm GA. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther. 1999;10:2245–2253.

    Article  PubMed  CAS  Google Scholar 

  2. Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak BH, Einhorn TA. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1–34). J Bone Joint Surg Am. 2005;87:731–741.

    Article  PubMed  Google Scholar 

  3. Al-Sayyad MJ. Taylor Spatial Frame in the treatment of pediatric and adolescent tibial shaft fractures. J Pediatr Orthop. 2006;26:164–170.

    PubMed  Google Scholar 

  4. Aoyama I, Anzai J, Nakamura T, Hiyama Y, Tamura M. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab. 2001;86:875–880.

    Article  PubMed  Google Scholar 

  5. Azuma J, Taniyama Y, Takeya Y, Iekushi K, Aoki M, Dosaka N, Matsumoto K, Nakamura T, Ogihara T, Morishita R. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther. 2006;13:1206–1213.

    Article  PubMed  CAS  Google Scholar 

  6. Baltzer AW, Lattermann C, Whalen JD, Ghivizzani S, Wooley P, Krauspe R, Robbins PD, Evans CH. Potential role of direct adenoviral gene transfer in enhancing fracture repair. Clin Orthop Relat Res. 2000;379:S120–125.

    Article  PubMed  Google Scholar 

  7. Bertone AL, Pittman DD, Bouxsein ML, Li J, Clancy B, Seeherman HJ. Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. J Orthop Res. 2004;22:1261–1270.

    Article  PubMed  CAS  Google Scholar 

  8. Betz OB, Betz VM, Nazarian A, Pilapil CG, Vrahas MS, Bouxsein ML, Gerstenfeld LC, Einhorn TA, Evans CH. Direct percutaneous gene delivery to enhance healing of segmental bone defect. J Bone Joint Surg Am. 2006;88:355–365.

    Article  PubMed  Google Scholar 

  9. Blanquaert F, Delany AM, Canalis E. Fibroblast growth factor-2 induces hepatocyte growth factor/scatter factor expression in osteoblasts. Endocrinology. 1999;140:1069–1074.

    Article  PubMed  CAS  Google Scholar 

  10. Chen WJ, Jingushi S, Aoyama I, Anzai J, Hirata G, Tamura M, Iwamoto Y. Effects of FGF-2 on metaphyseal fracture repair in rabbit tibiae. J Bone Miner Metab. 2004;22:303–309.

    Article  PubMed  CAS  Google Scholar 

  11. Chen Y, Cheung KM, Kung HF, Leong JC, Lu WW, Luk KD. In vivo new bone formation by direct transfer of adenoviral-mediated bone morphogenetic protein-4 gene. Biochem Biophys Res Commun. 2002;298:121–127.

    Article  PubMed  CAS  Google Scholar 

  12. D’Ippolito G, Schiller PC, Perez-stable C, Balkan W, Roos BA, Howard GA. Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cell. Bone. 2002;31:269–275.

    Article  PubMed  CAS  Google Scholar 

  13. Eckardt H, Ding M, Lind M, Hansen ES, Christensen KS, Hvid I. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br. 2005;87:1434–1438.

    Article  PubMed  CAS  Google Scholar 

  14. Egermann M, Goldhahn J, Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos Int. 2005;16:S129–138.

    Article  PubMed  Google Scholar 

  15. Egermann M, Lill CA, Griesbeck K, Evans CH, Robbins PD, Schneider E, Baltzer AW. Effect of BMP-2 gene transfer on bone healing in sheep. Gene Ther. 2006;13:1290–1299.

    Article  PubMed  CAS  Google Scholar 

  16. Einhorn TA. Enhancement of fracture-healing. J Bone Joint Surg Am. 1995;77:940–956.

    PubMed  CAS  Google Scholar 

  17. Einhorn TA, Majeska RJ, Mohaideen A, Kagel EM, Bouxsein ML, Turek TJ, Wozney JM. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am. 2003;85:1425–1435.

    PubMed  Google Scholar 

  18. Franceschi RT, Yang S, Rutherford RB, Krebsbach PH, Zhao M, Wang D. Gene therapy approaches for bone regeneration. Cells Tissues Organs. 2004;176:95–108.

    Article  PubMed  CAS  Google Scholar 

  19. Giannoudis PV, Tzioupis CC, Tsiridis E. Gene therapy in orthopaedics. Injury. 2006;37:S30–40.

    Article  PubMed  Google Scholar 

  20. Greiwe RM, Archdeacon MT. Locking plate technology: current concepts. J Knee Surg. 2007;20:50–55.

    PubMed  Google Scholar 

  21. Hirano S, Bless DM, Rousseau B, Welham N, Montequin D, Chan RW, Ford CN. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope. 2004;114:548–556.

    Article  PubMed  Google Scholar 

  22. Hossain M, Irwin R, Baumann MJ, McCabe LR. Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces. Biomaterials. 2005;26:2595–2602.

    Article  PubMed  CAS  Google Scholar 

  23. Ido A, Moriuchi A, Kim I, Numata M, Nagata Y, Hasuike S, Uto H, Tsubouchi H. Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatology Research. 2004;30:175–181.

    Article  PubMed  CAS  Google Scholar 

  24. Imai Y, Terai H, Nomura-Furuwatari C, Mizuno S, Matsumoto K, Nakamura T, Takaoka K. Hepatocyte growth factor contributes to fracture repair by upregulating the expression of BMP receptors. J Bone Miner Res. 2005;20:1723–1730.

    Article  PubMed  CAS  Google Scholar 

  25. Jin M, Chen Y, He S, Ryan SJ, Hinton DR. Hepatocyte growth factor and its role in the pathogenesis of retinal detachment. Invest Ophthalmol Vis Sci. 2004;45:323–329.

    Article  PubMed  Google Scholar 

  26. Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzuki N, Nakamura H, Morishita R, Kotani H. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther. 2002;6:219–226.

    Article  PubMed  CAS  Google Scholar 

  27. Kato N, Nemoto K, Nakanishi K, Morishita R, Kaneda Y, Uenoyama M, Ikeda T, Fujikawa K. Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve. Neurosci Res. 2005;52:299–310.

    Article  PubMed  CAS  Google Scholar 

  28. Koike H, Morishita R, Iguchi S, Aoki M, Matsumoto K, Nakamura T, Yokoyama C, Tanabe T, Ogihara T, Kaneda Y. Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene. FASEB J. 2003;17:779–781.

    PubMed  CAS  Google Scholar 

  29. Lane JM. Bone morphogenic protein science and studies. J Orthop Trauma. 2005;19:S17–22.

    Article  PubMed  Google Scholar 

  30. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am. 2002;84:1032–1044.

    PubMed  Google Scholar 

  31. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, Kabo JM, Finerman GA, Berk AJ, Witte ON. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am. 1999;81:905–917.

    PubMed  CAS  Google Scholar 

  32. Luo J, Sun MH, Kang Q, Peng Y, Jiang W, Luu HH, Luo Q, Park JY, Li Y, Haydon RC, He TC. Gene therapy for bone regeneration. Curr Gene Ther. 2005;5:167–179.

    Article  PubMed  CAS  Google Scholar 

  33. Matsushita T, Kurokawa T. Comparison of cyclic compression, cyclic distraction and rigid fixation. Bone healing in rabbits. Acta Orthop Scand. 1998;69:95–98.

    Article  PubMed  CAS  Google Scholar 

  34. Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J, Sawa Y, Matsuda H, Kaneda Y, Ogihara T. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension. 2004;44:203–209.

    Article  PubMed  CAS  Google Scholar 

  35. Musgrave DS, Bosch P, Ghivizzani S, Robbins PD, Evans CH, Huard J. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone. 1999;24:541–547.

    Article  PubMed  CAS  Google Scholar 

  36. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987;224:311–316.

    Article  PubMed  CAS  Google Scholar 

  37. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342:440–443.

    Article  PubMed  CAS  Google Scholar 

  38. Niyibizi C, Baltzer A, Lattermann C, Oyama M, Whalen JD, Robbins PD, Evans CH. Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop Relat Res. 1998;355:S148–153.

    Article  PubMed  Google Scholar 

  39. Oshima K, Shimamura M, Mizuno S, Tamai K, Doi K, Morishita R, Nakamura T, Kubo T, Kaneda Y. Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats. FASEB J. 2004;18:212–214.

    PubMed  CAS  Google Scholar 

  40. Park SH, O’Connor K, Sung R, McKellop H, Sarmiento A. Comparison of healing process in open osteotomy model and closed fracture model. J Orthop Trauma. 1999;13:114–120.

    Article  PubMed  CAS  Google Scholar 

  41. Park SH, Silva M. Effect of intermittent pneumatic soft-tissue compression on fracture-healing in an animal model. J Bone Joint Surg Am. 2003;85:1446–1453.

    PubMed  Google Scholar 

  42. Radomsky ML, Aufdemorte TB, Swain LD, Fox WC, Spiro RC, Poser JW. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res. 1999;17:607–614.

    Article  PubMed  CAS  Google Scholar 

  43. Rundle CH, Miyakoshi N, Kasukawa Y, Chen ST, Sheng MH, Wergedal JE, Lau KH, Baylink DJ. In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4. Bone. 2003;32:591–601.

    Article  PubMed  CAS  Google Scholar 

  44. Sekalska B, Ciechanowicz A, Dolegowska B, Naruszewicz M. Optimized RT-PCR method for assaying expression of monocyte chemotactic protein type 1 (MCP-1) in rabbit aorta. Biochem Genet. 2006;44:133–143.

    Article  PubMed  CAS  Google Scholar 

  45. Shi E, Jiang X, Kazui T, Washiyama N, Yamashita K, Terada H, Bashar AH. Nonviral gene transfer of hepatocyte growth factor attenuates neurologic injury after spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg. 2006;132:941–947.

    Article  PubMed  Google Scholar 

  46. Shimamura M, Morishita R, Endoh M, Oshima K, Aoki M, Waguri S, Uchiyama Y, Kaneda Y. HVJ-envelope vector for gene transfer into central nervous system. Biochem Biophys Res Commun. 2003;300:464–471.

    Article  PubMed  CAS  Google Scholar 

  47. Shimamura M, Sato N, Oshima K, Aoki M, Kurinami H, Waguri S, Uchiyama Y, Ogihara T, Kaneda Y, Morishita R. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation. 2004;109:424–431.

    Article  PubMed  CAS  Google Scholar 

  48. Southwood LL, Frisbie DD, Kawcak CE, McIlwraith CW. Delivery of growth factors using gene therapy to enhance bone healing. Vet Surg. 2004;33:565–578.

    Article  PubMed  Google Scholar 

  49. Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 2001;8:181–189.

    Article  PubMed  CAS  Google Scholar 

  50. Taniyama Y, Morishita R, Hiraoka K, Aoki M, Nakagami H, Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation. 2001;104:2344–2350.

    Article  PubMed  CAS  Google Scholar 

  51. Welch RD, Jones AL, Bucholz RW, Reinert CM, Tjia JS, Pierce WA, Wozney JM, Li XJ. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res. 1998;13:1483–1490.

    Article  PubMed  CAS  Google Scholar 

  52. Yoshimura S, Morishita R, Hayashi K, Kokuzawa J, Aoki M, Matsumoto K, Nakamura T, Ogihara T, Sakai N, Kaneda Y. Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model. Hypertension. 2002;39:1028–1034.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Yoh Zen, MD, PhD, Department of Pathology, Kanazawa University, for assistance in the histologic examination. Anges MG Inc (Tokyo, Japan) kindly supplied the hHGF expression vector.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroyuki Tsuchiya MD, PhD.

Additional information

Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.

Each author certifies that his or her institution has approved the animal protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.

About this article

Cite this article

Matsubara, H., Tsuchiya, H., Watanabe, K. et al. Percutaneous Nonviral Delivery of Hepatocyte Growth Factor in an Osteotomy Gap Promotes Bone Repair in Rabbits: A Preliminary Study. Clin Orthop Relat Res 466, 2962–2972 (2008). https://doi.org/10.1007/s11999-008-0493-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-008-0493-z

Keywords

Navigation